Publications by authors named "Xin-Xing Lai"
[Post-marketing study on clinical safety of ginkgo diterpene lactone meglumine injection in 6 300 patients with ischemic stroke].
Zhongguo Zhong Yao Za Zhi
December 2017
Article Synopsis
- A clinical safety study evaluated the use of ginkgo diterpene lactone meglumine injection in 6,300 ischemic stroke patients across 82 units from June 2013 to December 2014.
- The study revealed a low adverse reaction rate of 0.46%, with most (86.21%) being mild and transient, such as headaches and dizziness, while only 4 cases had moderate reactions.
- No serious adverse reactions were reported, indicating that the overall incidence of side effects was low and manageable.